Breaking News Instant updates and real-time market news.

WHR

Whirlpool

$131.06

-1.5 (-1.13%)

08:25
05/23/19
05/23
08:25
05/23/19
08:25

Whirlpool to host investor day

Investor day to be held in New York on May 23 at 9 am. Webcast Link

  • 23

    May

WHR Whirlpool
$131.06

-1.5 (-1.13%)

04/15/19
BUCK
04/15/19
NO CHANGE
Target $135
BUCK
Neutral
AHAM 6 appliance shipments drop 6% in March, says Buckingham
The Association of Home Appliance Manufacturers reported March appliance shipments were down 6% while total appliances were down 4%, Buckingham analyst Megan McGrath tells investors in a research note titled "AHAM Data for March Continues To Reflect Tariff." The overall unit decline was generally in line with the analyst's expectations, but she notes that weakness in the month extended beyond the Laundry category, which she calls "somewhat surprising." McGrath maintained her 4% North America revenue growth estimate for Whirlpool's Q1, as she continues to expect the company to outperform industry data and benefit from higher pricing. The analyst keeps a Neutral rating on Whirlpool with a $135 price target.
05/10/19
LBOW
05/10/19
UPGRADE
LBOW
Buy
Whirlpool upgraded to Buy from Neutral at Longbow
05/10/19
LBOW
05/10/19
UPGRADE
Target $178
LBOW
Buy
Longbow says NA margin fears misguided, upgrades Whirlpool to Buy
As previously reported, Longbow analyst David MacGregor upgraded Whirlpool to Buy from Neutral stating that he sees earnings upside from better than expected North American margin performance, a "gradually improving" environment in the EMEA and a favorable cyclical turn in Latin America. The stock is pricing in a substantial 2019/2020 EPS deterioration, but he views this as overly bearish and thinks the bear thesis built on expectations for deteriorating NA margins is "misguided." MacGregor, who raised his EPS forecasts for Whirlpool, set a $178 price target on the shares.
05/10/19
05/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. 3D Systems (DDD) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster noting the stock is down 25% this week after posting "lackluster" Q1 results. 2. Jones Lang LaSalle (JLL) upgraded to Buy from Neutral at Goldman Sachs with analyst Andrew Rosivach saying the company's earnings declined in Q1 due to tough comps, but this should reverse quickly. 3. Ford (F) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy stating the company's earnings are starting to hit a "sustainable inflection" due to favorable product cadence in the North America market and its restructuring efforts. 4. Whirlpool (WHR) upgraded to Buy from Neutral at Longbow with analyst David MacGregor seeing earnings upside from better than expected North American margin performance, a "gradually improving" environment in the EMEA and a favorable cyclical turn in Latin America. 5. Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) upgraded to Buy from Neutral at Citi with analyst Ralph Giacobbe the magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SNV

Synovus

$33.01

0.08 (0.24%)

07:15
06/17/19
06/17
07:15
06/17/19
07:15
Conference/Events
Synovus management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Breaking Hot Stocks news story on Array BioPharma, Pfizer »

Array BioPharma up 59% to…

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

PFE

Pfizer

$42.75

0.24 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

ALNY

Alnylam

$70.04

-1.15 (-1.62%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Alnylam announces lumasiran results, full patient enrollment in ILLUMINATE-A, »

Alnylam announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$11.35

-0.31 (-2.66%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Initiation
Amicus initiated  »

Amicus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 16

    Sep

PLX

Protalix

$0.42

-0.017 (-3.89%)

07:13
06/17/19
06/17
07:13
06/17/19
07:13
Hot Stocks
Protalix completes enrollment in Phase III Bright clinical trial of PRX-102 »

Protalix BioTherapeutics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$364.63

-0.43 (-0.12%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Conference/Events
Roper Technologies management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

07:12
06/17/19
06/17
07:12
06/17/19
07:12
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWLK

ReWalk Robotics

$5.21

-0.215 (-3.97%)

07:11
06/17/19
06/17
07:11
06/17/19
07:11
Upgrade
ReWalk Robotics rating change  »

ReWalk Robotics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGS

Orgenesis

$4.21

-0.09 (-2.09%)

07:11
06/17/19
06/17
07:11
06/17/19
07:11
Hot Stocks
Orgenesis gets Orphan Drug designation for Autologous Insulin Producing cells »

Orgenesis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMG

Cellular Biomedicine

$14.68

-0.62 (-4.05%)

07:09
06/17/19
06/17
07:09
06/17/19
07:09
Hot Stocks
Cellular Biomedicine: First patient dosed in Phase 1 trial of anti-CD20 CAR-T »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$14.10

0.06 (0.43%)

07:08
06/17/19
06/17
07:08
06/17/19
07:08
Hot Stocks
Universal Stainless & Alloy reports fire at North Jackson, Ohio facility »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.24

-0.37 (-4.30%)

07:08
06/17/19
06/17
07:08
06/17/19
07:08
Recommendations
Teva analyst commentary  »

Teva price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$117.48

-7.52 (-6.02%)

, CELG

Celgene

$96.49

0.07 (0.07%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
BeiGene, Celgene to terminate global collaboration for tislelizumab »

BeiGene (BGNE) announced…

BGNE

BeiGene

$117.48

-7.52 (-6.02%)

CELG

Celgene

$96.49

0.07 (0.07%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

TWIN

Twin Disc

$14.02

0.125 (0.90%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
Twin Disc names James Feiertag as president and COO, effective May 1 »

Twin Disc has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

, FANG

Diamondback Energy

$98.98

-1.15 (-1.15%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Initiation
Rattler Midstream, Diamondback Energy initiated  »

Rattler Midstream…

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

FANG

Diamondback Energy

$98.98

-1.15 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 13

    Sep

TYPE

Monotype Imaging

$16.33

0.01 (0.06%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Hot Stocks
Monotype Imaging CFO Anthony Callini to step down »

Monotype Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$19.21

-0.195 (-1.01%)

07:06
06/17/19
06/17
07:06
06/17/19
07:06
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
06/17/19
06/17
07:05
06/17/19
07:05
General news
FX Update: Trading has been directionally unambitious »

FX Update: Trading has…

CASI

Casi Pharmaceuticals

$3.13

-0.05 (-1.57%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Hot Stocks
Casi Pharmaceuticals acquires rights to commercialize anti-CD19 T-cell therapy »

CASI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

IDYA

Ideaya Biosciences

$10.70

-0.1 (-0.93%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Initiation
Ideaya Biosciences initiated  »

Ideaya Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$56.60

-0.82 (-1.43%)

07:04
06/17/19
06/17
07:04
06/17/19
07:04
Hot Stocks
Stifel Financial to acquire capital markets business of GMP Capital »

Stifel Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

ENDP

Endo

$4.04

-0.43 (-9.62%)

07:02
06/17/19
06/17
07:02
06/17/19
07:02
Downgrade
Endo rating change  »

Citi downgrades Endo to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDC

China Lending Corp.

$0.92

(0.00%)

07:02
06/17/19
06/17
07:02
06/17/19
07:02
Hot Stocks
China Lending Corp. to acquire equity interests in Cayman Lixin »

China Lending announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$42.75

0.24 (0.56%)

, ARRY

Array BioPharma

$29.59

0.17 (0.58%)

07:01
06/17/19
06/17
07:01
06/17/19
07:01
Hot Stocks
Pfizer to acquire Array BioPharma for $48.00 per share »

Pfizer (PFE) and Array…

PFE

Pfizer

$42.75

0.24 (0.56%)

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

QURE

uniQure

$72.65

1.27 (1.78%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

06:59
06/17/19
06/17
06:59
06/17/19
06:59
Periodicals
uniQure exploring options, including potential sale, Bloomberg reports »

Gene-therapy firm UniQure…

QURE

uniQure

$72.65

1.27 (1.78%)

PFE

Pfizer

$42.75

0.24 (0.56%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

NVO

Novo Nordisk

$50.96

-0.73 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 26

    Jun

  • 28

    Aug

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.